Loading

Short Communication Open Access
Volume 2 | Issue 2 | DOI: https://doi.org/10.46439/cancerbiology.2.023

Fertility treatments for men with hypogonadotropic hypogonadism

  • 1Subspeciality training fellow in Reproductive Medicine, St Michael’s Hospital, Bristol BS2 8EG, United Kingdom
  • 2Emeritus Professor in Medical Education and in Reproductive Medicine, Academic Unit of Obstetrics and Gynecology, St Michael’s Hospital, Bristol BS2 8EG, United Kingdom
+ Affiliations - Affiliations

Corresponding Author

Guy Morris, guychlsmorris@gmail.com

Received Date: April 06, 2021

Accepted Date: June 21, 2021

Abstract

The diagnosis of azoospermia is a devasting one for men – and it represents the obliteration of so many unspoken hopes and expectations. Most causes of azoospermia are not amenable to treatment but those due to hypogonadotropic hypogonadism can respond to gonadotropin therapy. This can be a lengthy and expensive treatment, but it delivers an opportunity to men to restore, albeit temporarily, their production of sperm. Encouragingly, treatment is associated with good success rates, even outside of specialist clinics. In this commentary, we present an understanding of the underlying pathophysiology in hypogonadotropic hypogonadism, together with a simple outline from leading clinics on the treatments used to induce spermatogenesis. We review options to consider before embarking on fertility-altering treatment in medicine and in surgery.   

Keywords

Gonadotrophins, Hypogonadotropic hypogonadism, Sperm count, Testicular volume (TV), Spermatogenesis, Children, Subfertility

Author Information X